Industry reports
Editor highlights

Search inside this page

Free Market Research Guides to Download

Biological Therapy Analysis & Statistics, April 2013 (p7)

You might be interested in: stem cell, cell therapy, tissue engineering, more »

» Purchase Premium Reports

181-210 of about 400 reports
Northwest Biotherapeutics, Inc. (Symbol:NWBO) SWOT Analysis, Strategy, Revenues and Profits

Northwest Biotherapeutics, Inc. (Symbol:NWBO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • April 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
Maxygen, Inc. (Symbol:MAXY) SWOT Analysis, Strategy, Revenues and Profits

Maxygen, Inc. (Symbol:MAXY) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • April 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
SkinEthic Laboratories - Strategic SWOT Analysis Review

SkinEthic Laboratories - Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • April 2013
  • by Global Data

SkinEthic Laboratories - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed ...

  • Industries : Biological Therapy
Bioheart, Inc. (BHRT) - Product Pipeline Analysis, 2013 Update

Bioheart, Inc. (BHRT) - Product Pipeline Analysis, 2013 Update

  • $ 750
  • Company report
  • April 2013
  • by Global Data

Summary Bioheart, Inc. (Bioheart) is a biotechnology company. It focus on the treatment of cardiovascular related diseases. It discovers, develops and commercializes autologous cell therapies to treat ...

  • Industries : Biological Therapy
  • Countries : United States
Bioheart, Inc. (Symbol:BHRT) SWOT Analysis, Strategy, Revenues and Profits

Bioheart, Inc. (Symbol:BHRT) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • April 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
Isis Pharmaceuticals, Inc. (Symbol:ISIS) SWOT Analysis, Strategy, Revenues and Profits

Isis Pharmaceuticals, Inc. (Symbol:ISIS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • April 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
Competitor Analysis: G-CSF and GM-CSF

Competitor Analysis: G-CSF and GM-CSF

  • $ 528
  • Industry report
  • April 2013
  • by La Merie Publishing

Product description The present Competitive Intelligence Report about G-CSF and GM-CSF product portfolios and R&D pipelines provides a competitor evaluation in the field of G-CSF & GM-CSF branded products ...

  • Industries : Biological Therapy
  • Countries : Taiwan, South Korea, India, China
B-Cell Leukemia - Pipeline Review, H1 2013

B-Cell Leukemia - Pipeline Review, H1 2013

  • $ 2 000
  • Industry report
  • February 2013
  • by Global Markets Direct

B-Cell Leukemia - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'B-Cell Leukemia - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides ...

  • Industries : Biological Therapy
  • Countries : World
World Biological Therapy: Natural Killer Cell Lymphomas - Pipeline Review, H1 2012

World Biological Therapy: Natural Killer Cell Lymphomas - Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • February 2013
  • by Global Markets Direct

This report provides information on the therapeutic development for Natural Killer Cell Lymphomas, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews ...

  • Industries : Biological Therapy
  • Countries : United States, World
Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2013

Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2013

  • $ 2 000
  • Industry report
  • February 2013
  • by Global Markets Direct

Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2013', provides an overview of the indication's ...

  • Industries : Biological Therapy
  • Countries : World, United States
Vitro Diagnostics, Inc. (VODG) - Medical Equipment - Deals and Alliances Profile

Vitro Diagnostics, Inc. (VODG) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2013
  • by Global Data

Summary Vitro Diagnostics, Inc. (Vitro Diagnostics) is a biopharmaceutical company, that carries out the development and commercialization of adult stem cell technology which is used for stem cell research, ...

  • Industries : Biological Therapy
  • Countries : United States
Tissue Therapies Limited (TIS) - Medical Equipment - Deals and Alliances Profile

Tissue Therapies Limited (TIS) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2013
  • by Global Data

Summary Tissue Therapies Limited (TTL) is a biomedical technology company, based in Australia. The company develops biomedical technologies for tissue repair, wound healing and cell culture applications. ...

  • Industries : Biological Therapy
  • Countries : Australia
The 2013 Report on Cancer Therapy Pharmaceuticals: World Market Segmentation by City

The 2013 Report on Cancer Therapy Pharmaceuticals: World Market Segmentation by City

  • $ 795
  • Industry report
  • January 2013
  • by ICON Group

This report was created for global strategic planners who cannot be content with traditional methods of segmenting world markets. With the advent of a “borderless world”, cities become a more important ...

  • Industries : Biological Therapy
  • Countries : World
Global Brachytherapy Devices Market 2012-2016

Global Brachytherapy Devices Market 2012-2016

  • $ 2 500
  • Industry report
  • January 2013
  • by Infiniti Research Limited

TechNavio's analysts forecast the Global Brachytherapy Devices market to grow at a CAGR of 2.85 percent over the period 2012-2016. One of the key factors contributing to this market growth is the significant ...

  • Industries : Biological Therapy
  • Countries : World
The 2013-2018 Outlook for Cancer Therapy Pharmaceuticals in Japan

The 2013-2018 Outlook for Cancer Therapy Pharmaceuticals in Japan

  • $ 495
  • Industry report
  • January 2013
  • by ICON Group

This econometric study covers the latent demand outlook for cancer therapy pharmaceuticals across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry ...

  • Industries : Biological Therapy
  • Countries : Japan
The 2013-2018 Outlook for Cancer Therapy Pharmaceuticals in the United States

The 2013-2018 Outlook for Cancer Therapy Pharmaceuticals in the United States

  • $ 495
  • Industry report
  • January 2013
  • by ICON Group

This econometric study covers the latent demand outlook for cancer therapy pharmaceuticals across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry ...

  • Industries : Biological Therapy
  • Countries : United States
The 2013-2018 World Outlook for Cancer Therapy Pharmaceuticals

The 2013-2018 World Outlook for Cancer Therapy Pharmaceuticals

  • $ 795
  • Industry report
  • January 2013
  • by ICON Group

This econometric study covers the world outlook for cancer therapy pharmaceuticals across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry ...

  • Industries : Biological Therapy
  • Countries : World
Cell Therapy Partnering Yearbook 2013

Cell Therapy Partnering Yearbook 2013

  • $ 1 495
  • Industry report
  • January 2013
  • by Currentpartnering

The Cell Therapy Partnering Yearbook 2013 report series provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare ...

  • Industries : Biological Therapy
Fanconi Anemia - Pipeline Review, H2 2012

Fanconi Anemia - Pipeline Review, H2 2012

  • $ 2 000
  • Company report
  • December 2012
  • by Global Markets Direct

Fanconi Anemia - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Fanconi Anemia - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides ...

  • Industries : Biological Therapy
  • Countries : World
Adenovirus Infections - Pipeline Review, H2 2012

Adenovirus Infections - Pipeline Review, H2 2012

  • $ 2 000
  • Company report
  • December 2012
  • by Global Markets Direct

Adenovirus Infections - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Adenovirus Infections - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This ...

  • Industries : Biological Therapy
  • Countries : World
Global Tissue Engineering and Cell Therapy Market 2011-2015

Global Tissue Engineering and Cell Therapy Market 2011-2015

  • $ 2 000
  • Industry report
  • December 2012
  • by Infiniti Research Limited

TechNavio's analysts forecast the Global Tissue Engineering and Cell Therapy market to grow at a CAGR of 18 percent over the period 2011-2015. One of the key factors contributing to this market growth ...

  • Industries : Biological Therapy
  • Countries : World
Stem Cell Therapy Market in Asia-Pacific to 2018 - Commercialization Supported by Favorable Government Policies, Strong Pipeline and Increased Licensing Activity

Stem Cell Therapy Market in Asia-Pacific to 2018 - Commercialization Supported by Favorable Government Policies, Strong Pipeline and Increased Licensing Activity

  • $ 3 500
  • Industry report
  • December 2012
  • by GBI Research

Stem Cell Therapy Market in Asia-Pacific to 2018 - Commercialization Supported by Favorable Government Policies, Strong Pipeline and Increased Licensing Activity Summary GBI Research, the leading business ...

  • Industries : Biological Therapy
  • Countries : South Korea
Small-Molecule Targeted Cancer Therapies: World Market 2013-2023

Small-Molecule Targeted Cancer Therapies: World Market 2013-2023

  • $ 2 621
  • Industry report
  • December 2012
  • by Visiongain

Report Details Cancer treatment with small molecules - your guide to trends and revenue prospects What does the future hold for small targeted agents to treat cancers? Visiongain's updated report gives ...

  • Industries : Biological Therapy
  • Countries : World, United States
Stem Cell Research Products: Opportunities, Tools & Technologies

Stem Cell Research Products: Opportunities, Tools & Technologies

  • $ 2 995
  • Industry report
  • December 2012
  • by BioInformant Worldwide, L.L.C.

Stem cells are primitive cells found in all multi-cellular organisms that are characterized by self-renewal and the capacity to differentiate into any mature cell type. Several broad categories of stem ...

  • Industries : Biological Therapy
  • Countries : United States
Indian Stem Cell Banking Market: Trends & Opportunities (2012-2017)

Indian Stem Cell Banking Market: Trends & Opportunities (2012-2017)

  • $ 700
  • Industry report
  • December 2012
  • by Daedal Research

Today, stem cell banking is being witnessed as one of the most promising and emerging fields of life sciences. The stem cell banking market is further expected to witness increased significant growth as ...

  • Industries : Biological Therapy
  • Countries : India
Liver Cirrhosis - Pipeline Review, H2 2012

Liver Cirrhosis - Pipeline Review, H2 2012

  • $ 2 000
  • Company report
  • November 2012
  • by Global Markets Direct

Liver Cirrhosis - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Liver Cirrhosis - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides ...

  • Industries : Biological Therapy
  • Countries : World
Sezary Syndrome - Pipeline Review, H2 2012

Sezary Syndrome - Pipeline Review, H2 2012

  • $ 2 000
  • Company report
  • November 2012
  • by Global Markets Direct

Sezary Syndrome - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Sezary Syndrome - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides ...

  • Industries : Biological Therapy
  • Countries : World
Sjogren%s Syndrome - Pipeline Review, H2 2012

Sjogren%s Syndrome - Pipeline Review, H2 2012

  • $ 2 000
  • Company report
  • November 2012
  • by Global Markets Direct

Sjogren's Syndrome - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Sjogren's Syndrome - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report ...

  • Industries : Biological Therapy
  • Countries : World, United States
The Market for Stem Cell Research Products: Current and Future Opportunities

The Market for Stem Cell Research Products: Current and Future Opportunities

  • $ 3 200
  • Industry report
  • November 2012
  • by BioInformatics

The market for stem cell research products continues to flourish. As stem cell research begins to yield actionable therapies, companies are investing resources in this area of research that stands to revolutionize ...

  • Industries : Biological Therapy
Plasma Cell Neoplasm - Pipeline Review, H2 2012

Plasma Cell Neoplasm - Pipeline Review, H2 2012

  • $ 2 000
  • Company report
  • October 2012
  • by Global Markets Direct

Plasma Cell Neoplasm - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Plasma Cell Neoplasm - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This ...

  • Industries : Biological Therapy
  • Countries : World

» View Public Reports

About 900 reports

Cell Culture Business (cell culture, cell therapy) in Thailand and The United States

  • Industry report
  • March 2014
  • 7 pages
  • by Research Paper

... cultured cells selected for high production of secondary metabolites (dicosmo and misawa, 1995). One way to increase the production level of secondary metabolites is by elicitation, which ...


» Read our Company Profiles

35 Companies

GlaxoSmithKline P.L.C.

United States

Bioheart Inc.

United States

StemCells Inc.

United States

Geron Corp.

United States

Osiris Therapeutics Inc.

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.